Effects of acute topiramate dosing on open field behavior in mice;Efeitos da administração aguda de topiramato sobre o comportamento de camundongos em campo aberto

Revista Neurociencias

Volumn 19, Issue 1, 2011, Pages 34-38

  Bertges, Klaus Ruback ^a   Bertges, Luiz Carlos ^a   de Souza, José Olimpio Tavares ^a   Machado, Juliana Clemente ^a   Mourao Junior, Carlos Alberto ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Behavior; Locomotor activity; Mice; Topiramate

Indexed keywords

TOPIRAMATE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXPLORATORY BEHAVIOR; IMMOBILIZATION; LEARNING; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; REARING; STRESS; VELOCITY;

EID: 79956365543     PISSN: 01043579     EISSN: None     Source Type: Journal    
DOI: 10.34024/rnc.2011.v19.8403     Document Type: Article

References (28)

1. Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol Res 1997;35:241-56.
2. Fisher R, Blum D. Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs. Epilepsia 1995;36:S105-14.
3. Vieta E, Gilabert A, Rodriguez A, Garcia-Castrillon A, Luna MJ, Arrufat E, et al. Effectiveness and safety of topiramate in treatment-resistant bipolar disorder. Actas Esp Psiquiatr 2001;29:148-52.
4. Maidment ID. The use of topiramate in mood stabilization. Ann Pharmacother 2002;36:1277-81.
5. Chong MS, Libretto SE. The rationale and use of topiramate for treating neuropathic pain. Clin J Pain 2003;19:59-68.
6. Dannon PN. Topiramate for the treatment of kleptomania: a case series and review of the literature. Clin Neuropharmacol 2003;26:1-4.
7. McGeeney BE. Topiramate in the treatment of cluster headache. Curr Pain Headache Rep 2003;7:135-8.
8. Johnson BA. Uses of topiramate in the treatment of alcohol dependence. Expert Rev Neurother 2004;4:751-8.
9. Astrup A, Toubro S. Topiramate: a new potential pharmacological treatment for obesity. Obes Res 2004;12:167S-73S.
10. Choi JW, Kim WK. Is topiramate a potential therapeutic agent for cerebral hypoxic/ischemic injury? Exp Neurol 2007;203:5-7.
11. Gomer B, Wagner K, Frings L, Saar J, Carius A, Harle M, et al. The influence of antiepileptic drugs on cognition: A comparison of levetiracetam with topiramate. Epilep Behav 2007;10:486-94.
12. Archer J. Tests for emotionality in rats and mice: a review. Anim Behav 1973;21:205-35.
13. Walsh RN, Cummins RA. The Open-Field Test: a critical review. Psychol Bull 83 1976;83:482-504.
14. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003;463:3-33.
15. Pedrazza EL, Riboldi GP, Pereira GS, Izquierdo I, Bonan CD. Habituation to an open field alters ecto-nucleotidase activities in rat hippocampal synaptosomes. Neurosci Lett 2007;413:21-4.
16. Izquierdo I, Izquierdo LA, Barros DM, Souza TM, Souza MM, Quevedo J, et al. Differential involvement of cortical receptor mechanisms in working, short-term and long-term memory. Behav Pharmacol 1998;9:421-7.
17. Tang V, Warden J, Cullen N, Rutledge E. Topiramate in traumatic brain injury: adverse effects on cognitive function. J Head Trauma Rehabil 2007;22:409-10.
18. Choleris E, Thomas AW, Kavaliers M, Prato FS. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev 2001;21:235-60.
19. Alaverdashvili M, Kubova H, Mares P. Motor performance and behavior of immature rats are not compromised by a high dose of topiramate. Epilepsy Behav 2005;7:222-30.
20. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999;283:397-401.
21. Jones SR, Gainetdinov RR, Caron MG. Application of microdialysis and voltammetry to assess dopamine functions in genetically altered mice: correlation with locomotor activity. Psychopharmacology (Berl) 1999;147:30-2.
22. Adriani W, Felici A, Sargolini F, Roullet P, Usiello A, Oliverio A, et al. N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes. Exp Brain Res 1998;123:52-9.
23. Johnson BA. Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence? Addict Behav 2004;29:1465-79.
24. Eltayb A, Wadenberg ML, Schilstrom B, Svensson TH. Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride. Naunyn Schmiedebergs Arch Pharmacol 2005;372:195-202.
25. Deutsch SI, Schwartz BL, Rosse RB, Mastropaolo J, Marvel CL, Drapalski AL. Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophrenia. Clin Neuropharmacol 2003;26:199-206.
26. Drapalski AL, Rosse RB, Peebles RR, Schwartz BL, Marvel CL, Deutsch SI. Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medication. Clin Neuropharmacol 2001;24:290-4.
27. Smith C. Drug Interactions between Psychoactive Agents and Antiepileptic Agents. Epilepsy Behav 2001;2:92-105.
28. Alvarez Jdo N, Fukushiro DF, Tatsu JA, Carvalho EP, Gandolfi AC, Tsuchiya JB, et al. Amphetamine-induced rapid-onset sensitization: role of novelty, conditioning and behavioral parameters. Pharmacol Biochem Behav 2006;83:500-7.